1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cataract Global Clinical Trials Review, H1, 2015

Cataract Global Clinical Trials Review, H1, 2015

  • June 2015
  • -
  • Global Data
  • -
  • 79 pages

Cataract Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H1, 2015" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Cataract Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cataract 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cataract 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Cataract Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Cataract 33
Apr 20, 2015: Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Valeant Pharmaceuticals International, Inc. 34
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 34
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Innovative Medical Products 38
Clinical Trial Overview of Innovative Medical Products 38
Actavis plc 39
Clinical Trial Overview of Actavis plc 39
Laboratoires Thea S.A. 40
Clinical Trial Overview of Laboratoires Thea S.A. 40
InSite Vision Incorporated 41
Clinical Trial Overview of InSite Vision Incorporated 41
Bucci Laser Vision 42
Clinical Trial Overview of Bucci Laser Vision 42
Omeros Corporation 43
Clinical Trial Overview of Omeros Corporation 43
Bausch and Lomb Incorporated 44
Clinical Trial Overview of Bausch and Lomb Incorporated 44
Abbott Laboratories 45
Clinical Trial Overview of Abbott Laboratories 45
Clinical Trial Overview of Top Institutes / Government 46
NHS Trusts Clinical Trials 46
Clinical Trial Overview of NHS Trusts Clinical Trials 46
Indiana University School of Medicine 47
Clinical Trial Overview of Indiana University School of Medicine 47
Moorfields Eye Hospital NHS Foundation Trust 48
Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 48
Department of Health, UK 49
Clinical Trial Overview of Department of Health, UK 49
National Eye Institute 50
Clinical Trial Overview of National Eye Institute 50
All India Institute of Medical Sciences 51
Clinical Trial Overview of All India Institute of Medical Sciences 51
Arak University of Medical Sciences 52
Clinical Trial Overview of Arak University of Medical Sciences 52
Capital Medical University 53
Clinical Trial Overview of Capital Medical University 53
Federal University of Sao Paulo 54
Clinical Trial Overview of Federal University of Sao Paulo 54
Het Oogziekenhuis Rotterdam 55
Clinical Trial Overview of Het Oogziekenhuis Rotterdam 55
Five Key Clinical Profiles 56
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables
Cataract Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cataract Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cataract Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Cataract Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cataract Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cataract Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cataract Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Cataract Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Cataract Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 34
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015* 38
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 39
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015* 40
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2015* 41
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bucci Laser Vision, 2015* 42
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015* 43
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch and Lomb Incorporated, 2015* 44
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 45
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Trusts Clinical Trials, 2015* 46
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015* 47
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015* 48
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 49
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 50
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 51
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 52
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015* 53
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 54
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Het Oogziekenhuis Rotterdam, 2015* 55

List of Figures
Cataract Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cataract Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cataract Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Cataract Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cataract Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Cataract Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.